Chemical subgroup
B02BD – Blutgerinnungsfaktoren
13Decisions
13Patient groups
Added benefit by patient group
- Non-quantifiable2
- Not proven11
Decisions, newest first
- 2024-02-15RefixiaNonacog beta pegolNot proven
- 2024-02-01AlprolixEftrenonacog alfaNot proven
- 2023-10-19HemgenixEtranacogen DezaparvovecNon-quantifiable
- 2023-03-16RoctavianValoctocogen roxaparvovecNon-quantifiable
- 2022-04-07IdelvionAlbutrepenonacog alfaNot proven
- 2020-02-06EsperoctTuroctocog alfa pegolNot proven
- 2019-06-20JiviDamoctocog alfa pegolNot proven
- 2018-11-01AdynoviRurioctocog alfa pegolNot proven
- 2018-04-19RefixiaNonacog beta pegolNot proven
- 2017-07-20AfstylaLonoctocog alfaNot proven
- 2016-06-16EloctaEfmoroctocog alfaNot proven
- 2015-05-07NuwiqSimoctocog alfaNot proven
- 2014-07-03NovoEightTuroctocog alfaNot proven
Data status: 2026-10-29